Bo Ringertz
Impact in
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
Papers in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 6
- Immune Response and Inflammation 5
-
- S100 Proteins and Annexins 4
- Co-authors
- Jan Palmblad (10 shared papers)Ingiäld Hafström (5 shared papers)Hans Gyllenhammar (7 shared papers)Curt Malmsten (2 shared papers)Olof Rådmark (1 shared paper)Mats Harms‐Ringdahl (1 shared paper)Johan Frostegård (1 shared paper)Lars L. Gustafsson (4 shared papers)
- Journals
- Basic & Clinical Pharmacology & Toxicology (2 papers)Biochimica et Biophysica Acta (BBA) - Bioenergetics (1 paper)Inflammation Research (1 paper)FEBS Letters (1 paper)Pharmacoepidemiology and Drug Safety (1 paper)
- Partner nations
- SwedenCanadaUnited States
In The Last Decade
Bo Ringertz
16 papers receiving 595 citations
Peers
Comparison fields: 5 of 102
- Geriatrics and Gerontology 63
- Applied Microbiology and Biotechnology 25
- Family Practice 24
- Pharmacology 68
- Immunology 132
Countries citing papers authored by Bo Ringertz
This map shows the geographic impact of Bo Ringertz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Ringertz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Ringertz more than expected).
Fields of papers citing papers by Bo Ringertz
This network shows the impact of papers produced by Bo Ringertz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Ringertz. The network helps show where Bo Ringertz may publish in the future.
Co-authors
The 25 scholars most cited alongside Bo Ringertz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 184 | |
| 2 | 2008 | 91 | |
| 3 | 1988 | 79 | |
| 4 | 1982 | 78 | |
| 5 | 1987 | 37 | |
| 6 | 1988 | 31 | |
| 7 | 1988 | 25 | |
| 8 | 2013 | 21 | |
| 9 | 1991 | 21 | |
| 10 | 1984 | 10 | |
| 11 | 1988 | 9 | |
| 12 | 1986 | 9 | |
| 13 | [A model for structured introduction of new drugs. The aim is to offer all patients appropriate treatment]. | 2008 | 7 |
| 14 | 1988 | 6 | |
| 15 | 1986 | 5 | |
| 16 | Extraction of Electronic Health Record Data in a Hospital Setting : Comparison of Automatic and Semi-Automatic Methods Using Anti-TNF Therapy as Model | 2012 | 2 |
About Bo Ringertz
Bo Ringertz is a scholar working on Immunology, Molecular Biology, Pediatrics, Perinatology and Child Health, Oncology and Pharmacology, having authored 16 papers that have together received 615 indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers), Immune Response and Inflammation (5 papers), S100 Proteins and Annexins (4 papers), Cytokine Signaling Pathways and Interactions (2 papers), Pharmaceutical studies and practices (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), Pharmacovigilance and Adverse Drug Reactions (1 paper) and Apelin-related biomedical research (1 paper). The work is most often cited by research in Geriatrics and Gerontology (63 citations), Applied Microbiology and Biotechnology (25 citations), Family Practice (24 citations), Pharmacology (68 citations) and Immunology (132 citations). Bo Ringertz has collaborated with scholars based in Sweden, Canada and United States. Frequent co-authors include Jan Palmblad, Ingiäld Hafström, Hans Gyllenhammar, Curt Malmsten, Olof Rådmark, Mats Harms‐Ringdahl, Johan Frostegård, Lars L. Gustafsson, Björn Wettermark and Ulf Bergman. Their work appears in journals such as Basic & Clinical Pharmacology & Toxicology, Biochimica et Biophysica Acta (BBA) - Bioenergetics, Inflammation Research, FEBS Letters and Pharmacoepidemiology and Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.